CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional paid-in capital	Treasury stock	Accumulated other comprehensive loss	Accumulated deficit
Balance at Dec. 31, 2023	$ 78,116	$ 14	$ 1,230,484	$ (25,097)	$ (8,323)	$ (1,118,962)
Balance, shares at Dec. 31, 2023		139,245
Stock-based compensation	17,322		17,322
Common stock issued for warrant exercises	150		150
Common stock issued for warrant exercises, shares		30
Common stock issued for stock option exercises	156		156
Common stock issued for stock option exercises, shares		56
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liablity	(7,560)		(7,560)
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liablity, shares		3,079
Purchase of capped calls	0
Reclassification of equity-based liability	327		327
Foreign currency translation adjustments	(2,464)				(2,464)
Net loss	(48,495)					(48,495)
Balance at Mar. 31, 2024	37,552	$ 14	1,240,879	(25,097)	(10,787)	(1,167,457)
Balance, shares at Mar. 31, 2024		142,410
Balance at Dec. 31, 2024	(14,169)	$ 14	1,305,677	(25,097)	(13,678)	(1,281,085)
Balance, shares at Dec. 31, 2024		144,129
Stock-based compensation	22,318		22,318
Common stock issued for stock option exercises	505		505
Common stock issued for stock option exercises, shares		150
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liablity	(3,416)	$ 1	(3,417)
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liablity, shares		2,627
Purchase of capped calls	(42,485)		(42,485)
Foreign currency translation adjustments	3,215				3,215
Net loss	(51,907)					(51,907)
Balance at Mar. 31, 2025	$ (85,939)	$ 15	$ 1,282,598	$ (25,097)	$ (10,463)	$ (1,332,992)
Balance, shares at Mar. 31, 2025		146,906